AVY Stock Analysis: Avery Dennison | NYSE
Packaging & Containers | NYSE, USA | Market Cap: 13.923m USD | 12M Return: 4.7% | US0536111091 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 143M
EPS Trend: 89.8%
Qual. Beats: 1
Rev. Trend: 95.5%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Avery Dennison Corporation is a global materials science and digital identification company that produces pressure-sensitive label materials, performance tapes, and graphics/reflective products. Its label offerings include papers, plastic films, and metal foils sold under the Fasson, JAC, and Avery Dennison brands, while its graphics segment supplies cast and reflective films for construction, automotive, fleet, and signage applications under the Avery Dennison and Mactac names. The pressure-sensitive label industry is a sizable segment of the global packaging value chain, driven by demand from consumer goods, food and beverage, and logistics end markets.
Beyond materials, Avery Dennison provides branding solutions, RFID-based information systems for inventory and supply chain visibility, and shelf-edge media products marketed under the Vestcom brand. Its customers span home and personal care, apparel, general retail, e-commerce, logistics, food and grocery, pharmaceuticals, and automotive industries across North America, Europe, the Middle East, North Africa, Asia, and Latin America. The company was founded in 1935, is headquartered in Mentor, Ohio, and adopted its current name in 1990 after previously operating as Avery International Corporation.
- RFID intelligent label adoption accelerates Solutions Group revenue growth
- Raw material cost inflation pressures label materials segment margins
- Sustainability regulations drive demand for recycled and recyclable label substrates
| Net Income: 704.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 4.13 > 1.0 |
| NWC/Revenue: 4.28% < 20% (prev 1.39%; Δ 2.88% < -1%) |
| CFO/TA 0.13 > 3% & CFO 1.23b > Net Income 704.9m |
| Net Debt (3.45b) to EBITDA (1.49b): 2.31 < 3 |
| Current Ratio: 1.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (76.7m) vs 12m ago -2.04% < -2% |
| Gross Margin: 28.98% > 18% (prev 28.57%; Δ 0.41% > 0.5%) |
| Asset Turnover: 104.0% > 50% (prev 102.0%; Δ 2.04% > 0%) |
| Interest Coverage Ratio: 8.08 > 6 (EBIT TTM 1.15b / Interest Expense TTM 142.0m) |
| A: 0.04 (Total Current Assets 3.40b - Total Current Liabilities 3.00b) / Total Assets 9.21b |
| B: 0.63 (Retained Earnings 5.84b / Total Assets 9.21b) |
| C: 0.13 (EBIT TTM 1.15b / Avg Total Assets 8.89b) |
| D: 0.34 (Book Value of Equity 2.32b / Total Liabilities 6.89b) |
| Altman-Z'' = 3.57 = A |
| DSRI: 1.04 (Receivables 1.79b/1.63b, Revenue 9.25b/8.74b) |
| GMI: 0.99 (GM 28.57% / 28.98%) |
| AQI: 1.04 (AQ_t 0.46 / AQ_t-1 0.44) |
| SGI: 1.06 (Revenue 9.25b / 8.74b) |
| TATA: -0.06 (NI 704.9m - CFO 1.23b) / TA 9.21b) |
| Beneish M = -2.95 (Cap -4..+1) = A |
As of August 26, 2026, the stock is trading at USD 179.95 with a total of 692,790 shares traded. Over the past week, the price has changed by +1.26%, over one month by +10.38%, over three months by +13.33% and over the past year by +4.69%.
Current recommended Stop Loss: 169.90 (which is 5.6% or 2 ATR below the current price).
Avery Dennison has received a consensus analysts rating of 4.45. Therefore, it is recommended to buy AVY.
- StrongBuy: 7
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 201.8 | 12.1% |
P/E Trailing = 20.0776
P/E Forward = 18.1818
P/S = 1.5055
P/B = 5.9941
P/EG = 1.7639
Revenue TTM = 9.25b USD
EBIT TTM = 1.15b USD
EBITDA TTM = 1.49b USD
Long Term Debt = 3.18b USD (from longTermDebt, last quarter)
Short Term Debt = 500.5m USD (from shortTermDebt, last quarter)
Debt = 3.68b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.45b USD (calculated: Debt 3.68b - CCE 227.3m)
Enterprise Value = 17.4b USD (13.9b + Debt 3.68b - CCE 227.3m)
Interest Coverage Ratio = 8.08 (Ebit TTM 1.15b / Interest Expense TTM 142.0m)
EV/FCF = 16.34x (Enterprise Value 17.4b / FCF TTM 1.06b)
FCF Yield = 6.12% (FCF TTM 1.06b / Enterprise Value 17.4b)
FCF Margin = 11.50% (FCF TTM 1.06b / Revenue TTM 9.25b)
Net Margin = 7.62% (Net Income TTM 704.9m / Revenue TTM 9.25b)
Gross Margin = 28.98% ((Revenue TTM 9.25b - Cost of Revenue TTM 6.57b) / Revenue TTM)
Gross Margin QoQ = 29.62% (prev 28.92%)
Tobins Q-Ratio = 1.89 (Enterprise Value 17.4b / Total Assets 9.21b)
Interest Expense / Debt = 3.86% (Interest Expense 142.0m / Debt 3.68b)
Taxrate = 27.01% (260.8m / 965.7m)
NOPAT = 838.0m (EBIT 1.15b * (1 - 27.01%))
Current Ratio = 1.13 (Total Current Assets 3.40b / Total Current Liabilities 3.00b)
Debt / Equity = 1.58 (Debt 3.68b / totalStockholderEquity, last quarter 2.32b)
Debt / EBITDA = 2.31 (Net Debt 3.45b / EBITDA 1.49b)
Debt / FCF = 3.25 (Net Debt 3.45b / FCF TTM 1.06b)
Total Stockholder Equity = 2.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.93% (Net Income 704.9m / Total Assets 9.21b)
RoE = 31.07% (Net Income TTM 704.9m / Total Stockholder Equity 2.27b)
RoCE = 21.08% (EBIT 1.15b / Capital Employed (Equity 2.27b + L.T.Debt 3.18b))
RoIC = 12.93% (NOPAT 838.0m / Invested Capital 6.48b)
WACC = 6.60% (E(13.9b)/V(17.6b) * Re(7.60%) + D(3.68b)/V(17.6b) * Rd(3.86%) * (1-Tc(0.27)))
Discount Rate = 7.60% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.01 | Cagr: -2.40%
[DCF] Terminal Value 77.97% ; FCFF base≈892.0m ; Y1≈1.02b ; Y5≈1.50b
[DCF] Fair Price = 253.3 (EV 22.6b - Net Debt 3.45b = Equity 19.2b / Shares 75.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 89.84 | EPS CAGR: 9.69% | SUE: 4.0 | # QB: 1
Revenue Correlation: 95.53 | Revenue CAGR: 3.31% | SUE: 4.0 | # QB: 2
EPS current Quarter (2026-09-30): EPS=2.33 | Chg30d=-6.56% | Revisions=-77% | Analysts=10
EPS current Year (2026-12-31): EPS=10.17 | Chg30d=+1.56% | Revisions=+77% | GrowthEPS=+6.7% | GrowthRev=+5.5%
EPS next Year (2027-12-31): EPS=11.19 | Chg30d=+0.76% | Revisions=+55% | GrowthEPS=+10.0% | GrowthRev=+3.1%
[Analyst] Revisions Ratio: +19% (up=17, down=11)